These data support the theory that the HH signaling pathway is the initial driver of BSC and that this tumor probably originates as a BCC that partially squamatizes through the accumulation of ARID1A mutations and RAS/MAPK pathway activation [30,39]. The gene discussed is ARID1A; the disease is neoplasm.